ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tofacitinib Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-16V9597
Home | Market Reports | Health| Pharmacy
Global Tofacitinib Market Insights and Forecast to 2028
BUY CHAPTERS

Global Tofacitinib Market Research Report 2025

Code: QYRE-Auto-16V9597
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Globe Pharmaceuticals
Delta Pharma Limited
Beacon Pharmaceuticals
Drug International

Tofacitinib Market

The global market for Tofacitinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tofacitinib is a prescription medication that belongs to a class of drugs called kinase inhibitors. It is used to treat certain inflammatory conditions in people who have already tried tumor necrosis factor (TNF) blockers. It is a disease modifying anti-rheumatic drug (DMARD), which works by suppressing the immune system. Tofacitinib is available in the form of a tablet (Xeljanz), an extended release tablet (Xeljanz XR) and as an oral solution. It is a janus kinase (JAK) inhibitor, which blocks the activity of the ALK protein, which helps cancer cells grow and spread. Tofacitinib can be used as a first-line treatment or after other treatments have failed.
The future market trends of Tofacitinib are expected to be positive, as the demand for effective and targeted therapies for lung cancer is increasing. Tofacitinib has shown superior efficacy and safety compared to other ALK inhibitors, such as crizotinib, especially in preventing or delaying brain metastases, which are common in ALK-positive NSCLC patients. Moreover, Tofacitinib is being investigated for other indications and combinations, such as ALK-positive anaplastic large cell lymphoma, ROS1-positive NSCLC, and Tofacitinib plus bevacizumab. These factors are likely to boost the market growth of Tofacitinib in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tofacitinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tofacitinib.
The Tofacitinib market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tofacitinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tofacitinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tofacitinib Market Report

Report Metric Details
Report Name Tofacitinib Market
Segment by Type
  • 5mg*60 Tablets
  • 5mg*10 Tablets
  • 10mg*10 Tablets
  • 5mg*30 Tablets
  • 5mg*14 Tablets
  • 10mg*14 Tablets
Segment by Application
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Psoriasis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Globe Pharmaceuticals, Delta Pharma Limited, Beacon Pharmaceuticals, Drug International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tofacitinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tofacitinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tofacitinib Market report?

Ans: The main players in the Tofacitinib Market are Pfizer, Globe Pharmaceuticals, Delta Pharma Limited, Beacon Pharmaceuticals, Drug International

What are the Application segmentation covered in the Tofacitinib Market report?

Ans: The Applications covered in the Tofacitinib Market report are Rheumatoid Arthritis, Ulcerative Colitis, Psoriasis, Others

What are the Type segmentation covered in the Tofacitinib Market report?

Ans: The Types covered in the Tofacitinib Market report are 5mg*60 Tablets, 5mg*10 Tablets, 10mg*10 Tablets, 5mg*30 Tablets, 5mg*14 Tablets, 10mg*14 Tablets

1 Tofacitinib Market Overview
1.1 Product Definition
1.2 Tofacitinib by Type
1.2.1 Global Tofacitinib Market Value Comparison by Type (2024 VS 2031)
1.2.2 5mg*60 Tablets
1.2.3 5mg*10 Tablets
1.2.4 10mg*10 Tablets
1.2.5 5mg*30 Tablets
1.2.6 5mg*14 Tablets
1.2.7 10mg*14 Tablets
1.3 Tofacitinib by Application
1.3.1 Global Tofacitinib Market Value by Application (2024 VS 2031)
1.3.2 Rheumatoid Arthritis
1.3.3 Ulcerative Colitis
1.3.4 Psoriasis
1.3.5 Others
1.4 Global Tofacitinib Market Size Estimates and Forecasts
1.4.1 Global Tofacitinib Revenue 2020-2031
1.4.2 Global Tofacitinib Sales 2020-2031
1.4.3 Global Tofacitinib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tofacitinib Market Competition by Manufacturers
2.1 Global Tofacitinib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tofacitinib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tofacitinib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tofacitinib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tofacitinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tofacitinib, Product Type & Application
2.7 Global Key Manufacturers of Tofacitinib, Date of Enter into This Industry
2.8 Global Tofacitinib Market Competitive Situation and Trends
2.8.1 Global Tofacitinib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tofacitinib Players Market Share by Revenue
2.8.3 Global Tofacitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tofacitinib Market Scenario by Region
3.1 Global Tofacitinib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tofacitinib Sales by Region: 2020-2031
3.2.1 Global Tofacitinib Sales by Region: 2020-2025
3.2.2 Global Tofacitinib Sales by Region: 2026-2031
3.3 Global Tofacitinib Revenue by Region: 2020-2031
3.3.1 Global Tofacitinib Revenue by Region: 2020-2025
3.3.2 Global Tofacitinib Revenue by Region: 2026-2031
3.4 North America Tofacitinib Market Facts & Figures by Country
3.4.1 North America Tofacitinib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tofacitinib Sales by Country (2020-2031)
3.4.3 North America Tofacitinib Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tofacitinib Market Facts & Figures by Country
3.5.1 Europe Tofacitinib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tofacitinib Sales by Country (2020-2031)
3.5.3 Europe Tofacitinib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tofacitinib Market Facts & Figures by Region
3.6.1 Asia Pacific Tofacitinib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tofacitinib Sales by Region (2020-2031)
3.6.3 Asia Pacific Tofacitinib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tofacitinib Market Facts & Figures by Country
3.7.1 Latin America Tofacitinib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tofacitinib Sales by Country (2020-2031)
3.7.3 Latin America Tofacitinib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tofacitinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Tofacitinib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tofacitinib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tofacitinib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tofacitinib Sales by Type (2020-2031)
4.1.1 Global Tofacitinib Sales by Type (2020-2025)
4.1.2 Global Tofacitinib Sales by Type (2026-2031)
4.1.3 Global Tofacitinib Sales Market Share by Type (2020-2031)
4.2 Global Tofacitinib Revenue by Type (2020-2031)
4.2.1 Global Tofacitinib Revenue by Type (2020-2025)
4.2.2 Global Tofacitinib Revenue by Type (2026-2031)
4.2.3 Global Tofacitinib Revenue Market Share by Type (2020-2031)
4.3 Global Tofacitinib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tofacitinib Sales by Application (2020-2031)
5.1.1 Global Tofacitinib Sales by Application (2020-2025)
5.1.2 Global Tofacitinib Sales by Application (2026-2031)
5.1.3 Global Tofacitinib Sales Market Share by Application (2020-2031)
5.2 Global Tofacitinib Revenue by Application (2020-2031)
5.2.1 Global Tofacitinib Revenue by Application (2020-2025)
5.2.2 Global Tofacitinib Revenue by Application (2026-2031)
5.2.3 Global Tofacitinib Revenue Market Share by Application (2020-2031)
5.3 Global Tofacitinib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Tofacitinib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Tofacitinib Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Globe Pharmaceuticals
6.2.1 Globe Pharmaceuticals Company Information
6.2.2 Globe Pharmaceuticals Description and Business Overview
6.2.3 Globe Pharmaceuticals Tofacitinib Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Globe Pharmaceuticals Tofacitinib Product Portfolio
6.2.5 Globe Pharmaceuticals Recent Developments/Updates
6.3 Delta Pharma Limited
6.3.1 Delta Pharma Limited Company Information
6.3.2 Delta Pharma Limited Description and Business Overview
6.3.3 Delta Pharma Limited Tofacitinib Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Delta Pharma Limited Tofacitinib Product Portfolio
6.3.5 Delta Pharma Limited Recent Developments/Updates
6.4 Beacon Pharmaceuticals
6.4.1 Beacon Pharmaceuticals Company Information
6.4.2 Beacon Pharmaceuticals Description and Business Overview
6.4.3 Beacon Pharmaceuticals Tofacitinib Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beacon Pharmaceuticals Tofacitinib Product Portfolio
6.4.5 Beacon Pharmaceuticals Recent Developments/Updates
6.5 Drug International
6.5.1 Drug International Company Information
6.5.2 Drug International Description and Business Overview
6.5.3 Drug International Tofacitinib Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Drug International Tofacitinib Product Portfolio
6.5.5 Drug International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tofacitinib Industry Chain Analysis
7.2 Tofacitinib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tofacitinib Production Mode & Process Analysis
7.4 Tofacitinib Sales and Marketing
7.4.1 Tofacitinib Sales Channels
7.4.2 Tofacitinib Distributors
7.5 Tofacitinib Customer Analysis
8 Tofacitinib Market Dynamics
8.1 Tofacitinib Industry Trends
8.2 Tofacitinib Market Drivers
8.3 Tofacitinib Market Challenges
8.4 Tofacitinib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Globe Pharmaceuticals
Delta Pharma Limited
Beacon Pharmaceuticals
Drug International
List of Tables
 Table 1. Global Tofacitinib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tofacitinib Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tofacitinib Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tofacitinib Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Tofacitinib Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tofacitinib Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tofacitinib Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tofacitinib Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tofacitinib, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tofacitinib, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tofacitinib, Product Type & Application
 Table 12. Global Key Manufacturers of Tofacitinib, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tofacitinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tofacitinib as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tofacitinib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tofacitinib Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Tofacitinib Sales Market Share by Region (2020-2025)
 Table 19. Global Tofacitinib Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Tofacitinib Sales Market Share by Region (2026-2031)
 Table 21. Global Tofacitinib Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tofacitinib Revenue Market Share by Region (2020-2025)
 Table 23. Global Tofacitinib Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tofacitinib Revenue Market Share by Region (2026-2031)
 Table 25. North America Tofacitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tofacitinib Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Tofacitinib Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Tofacitinib Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tofacitinib Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tofacitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tofacitinib Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Tofacitinib Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Tofacitinib Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tofacitinib Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tofacitinib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tofacitinib Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Tofacitinib Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Tofacitinib Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tofacitinib Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tofacitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tofacitinib Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Tofacitinib Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Tofacitinib Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tofacitinib Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tofacitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tofacitinib Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Tofacitinib Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Tofacitinib Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tofacitinib Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tofacitinib Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Tofacitinib Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Tofacitinib Sales Market Share by Type (2020-2025)
 Table 53. Global Tofacitinib Sales Market Share by Type (2026-2031)
 Table 54. Global Tofacitinib Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tofacitinib Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tofacitinib Revenue Market Share by Type (2020-2025)
 Table 57. Global Tofacitinib Revenue Market Share by Type (2026-2031)
 Table 58. Global Tofacitinib Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Tofacitinib Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Tofacitinib Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Tofacitinib Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Tofacitinib Sales Market Share by Application (2020-2025)
 Table 63. Global Tofacitinib Sales Market Share by Application (2026-2031)
 Table 64. Global Tofacitinib Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tofacitinib Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tofacitinib Revenue Market Share by Application (2020-2025)
 Table 67. Global Tofacitinib Revenue Market Share by Application (2026-2031)
 Table 68. Global Tofacitinib Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Tofacitinib Price (USD/Pcs) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Pfizer Tofacitinib Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Globe Pharmaceuticals Company Information
 Table 76. Globe Pharmaceuticals Description and Business Overview
 Table 77. Globe Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Globe Pharmaceuticals Tofacitinib Product
 Table 79. Globe Pharmaceuticals Recent Developments/Updates
 Table 80. Delta Pharma Limited Company Information
 Table 81. Delta Pharma Limited Description and Business Overview
 Table 82. Delta Pharma Limited Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Delta Pharma Limited Tofacitinib Product
 Table 84. Delta Pharma Limited Recent Developments/Updates
 Table 85. Beacon Pharmaceuticals Company Information
 Table 86. Beacon Pharmaceuticals Description and Business Overview
 Table 87. Beacon Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Beacon Pharmaceuticals Tofacitinib Product
 Table 89. Beacon Pharmaceuticals Recent Developments/Updates
 Table 90. Drug International Company Information
 Table 91. Drug International Description and Business Overview
 Table 92. Drug International Tofacitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Drug International Tofacitinib Product
 Table 94. Drug International Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Tofacitinib Distributors List
 Table 98. Tofacitinib Customers List
 Table 99. Tofacitinib Market Trends
 Table 100. Tofacitinib Market Drivers
 Table 101. Tofacitinib Market Challenges
 Table 102. Tofacitinib Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tofacitinib
 Figure 2. Global Tofacitinib Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tofacitinib Market Share by Type: 2024 & 2031
 Figure 4. 5mg*60 Tablets Product Picture
 Figure 5. 5mg*10 Tablets Product Picture
 Figure 6. 10mg*10 Tablets Product Picture
 Figure 7. 5mg*30 Tablets Product Picture
 Figure 8. 5mg*14 Tablets Product Picture
 Figure 9. 10mg*14 Tablets Product Picture
 Figure 10. Global Tofacitinib Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Tofacitinib Market Share by Application: 2024 & 2031
 Figure 12. Rheumatoid Arthritis
 Figure 13. Ulcerative Colitis
 Figure 14. Psoriasis
 Figure 15. Others
 Figure 16. Global Tofacitinib Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Tofacitinib Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Tofacitinib Sales (2020-2031) & (K Pcs)
 Figure 19. Global Tofacitinib Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Tofacitinib Report Years Considered
 Figure 21. Tofacitinib Sales Share by Manufacturers in 2024
 Figure 22. Global Tofacitinib Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Tofacitinib Players: Market Share by Revenue in Tofacitinib in 2024
 Figure 24. Tofacitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Tofacitinib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Tofacitinib Sales Market Share by Country (2020-2031)
 Figure 27. North America Tofacitinib Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Tofacitinib Sales Market Share by Country (2020-2031)
 Figure 31. Europe Tofacitinib Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Tofacitinib Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Tofacitinib Revenue Market Share by Region (2020-2031)
 Figure 39. China Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Tofacitinib Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Tofacitinib Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Tofacitinib Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Tofacitinib Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Tofacitinib Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Tofacitinib by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Tofacitinib by Type (2020-2031)
 Figure 61. Global Tofacitinib Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Tofacitinib by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Tofacitinib by Application (2020-2031)
 Figure 64. Global Tofacitinib Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Tofacitinib Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Tofacitinib Citrate Market Research Report 2025
Global Tofacitinib Citrate API Market Research Report 2025
Global Upadacitinib API Market Research Report 2024
Global Crizotinib Market Research Report 2024
Global Tucatinib Market Research Report 2025
Global Ceritinib Market Research Report 2024
Global Gefitinib Market Research Report 2024
Global Fostamatinib Market Research Report 2024
Global Regorafenib Market Research Report 2024
Tocilizumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Afatinib Market Research Report 2024
Global Anlotinib Market Research Report 2024
Global Capecitabine Tablets Market Research Report 2024
Global Osimertinib Market Research Report 2024
Global Famotidine Drugs Market Research Report 2025
Global Palbociclib Market Research Report 2024
Global Guadecitabine Market Research Report 2025
Global Ibrutinib Market Research Report 2024
Global Sonidegib Market Research Report 2025
Global Pazopanib Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions